Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats

Objectives: Trimethylamine N-oxide (TMAO), a metabolic product of gut flora, is increased in chronic kidney disease (CKD) subjects and is recognized as one type of uremic toxins which is associated with poor cardiovascular outcomes and kidney function loss. Previous studies have suggested that rhuba...

Full description

Saved in:
Bibliographic Details
Main Authors: Chunlan Ji (Author), Yin Li (Author), Yenan Mo (Author), Zhaoyu Lu (Author), Fuhua Lu (Author), Qizhan Lin (Author), Xusheng Liu (Author), Chuan Zou (Author), Yuchi Wu (Author)
Format: Book
Published: Frontiers Media S.A., 2021-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ff84a8e94bf24e1aa1b176f84dbb0613
042 |a dc 
100 1 0 |a Chunlan Ji  |e author 
700 1 0 |a Chunlan Ji  |e author 
700 1 0 |a Chunlan Ji  |e author 
700 1 0 |a Yin Li  |e author 
700 1 0 |a Yin Li  |e author 
700 1 0 |a Yin Li  |e author 
700 1 0 |a Yenan Mo  |e author 
700 1 0 |a Yenan Mo  |e author 
700 1 0 |a Yenan Mo  |e author 
700 1 0 |a Zhaoyu Lu  |e author 
700 1 0 |a Zhaoyu Lu  |e author 
700 1 0 |a Zhaoyu Lu  |e author 
700 1 0 |a Fuhua Lu  |e author 
700 1 0 |a Fuhua Lu  |e author 
700 1 0 |a Fuhua Lu  |e author 
700 1 0 |a Qizhan Lin  |e author 
700 1 0 |a Qizhan Lin  |e author 
700 1 0 |a Qizhan Lin  |e author 
700 1 0 |a Xusheng Liu  |e author 
700 1 0 |a Xusheng Liu  |e author 
700 1 0 |a Xusheng Liu  |e author 
700 1 0 |a Chuan Zou  |e author 
700 1 0 |a Chuan Zou  |e author 
700 1 0 |a Chuan Zou  |e author 
700 1 0 |a Yuchi Wu  |e author 
700 1 0 |a Yuchi Wu  |e author 
700 1 0 |a Yuchi Wu  |e author 
245 0 0 |a Rhubarb Enema Decreases Circulating Trimethylamine N-Oxide Level and Improves Renal Fibrosis Accompanied With Gut Microbiota Change in Chronic Kidney Disease Rats 
260 |b Frontiers Media S.A.,   |c 2021-12-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2021.780924 
520 |a Objectives: Trimethylamine N-oxide (TMAO), a metabolic product of gut flora, is increased in chronic kidney disease (CKD) subjects and is recognized as one type of uremic toxins which is associated with poor cardiovascular outcomes and kidney function loss. Previous studies have suggested that rhubarb enema could reduce circulating uremic toxins such as urea, creatinine, and indoxyl sulfate and also regulate the intestinal microbiota. However, whether rhubarb enema retards kidney dysfunction by reducing circulating TMAO and its underlying mechanism, are still unclear. The present study aims to investigate the impact of rhubarb enema on TMAO and its precursors, as well as on the intestinal microbiota in 5/6 nephrectomized (5/6Nx) CKD rats.Design: Rats in the treatment groups were given rhubarb enema after modeling. At the end of the study, blood, feces, and kidney tissues were collected and processed for biochemical analyses, histological and western blot analyses, 16S rRNA sequence and untargeted metabolomic analyses.Results: Rhubarb enema reduced serum TMAO and trimethylamine (TMA) levels, inhibited the expression of inflammatory markers (interleukin-6, tumor necrosis factor α and Interferon-γ) and alleviated tubular atrophy, monocyte infiltration and interstitial fibrosis in 5/6Nx CKD rats. Moreover, rhubarb enema significantly increased the abundance of some symbiotic bacteria and probiotics, while reduced the abundance of some potential pathogens at the genus level. In addition, Spearman's correlation analysis revealed that lachnospiraceae and romboutsia were positively correlated with TMAO.Conclusion: Rhubarb enema decreases circulating TMAO level and improves renal fibrosis in 5/6Nx CKD rats, which may be related to the regulation of intestinal microbial community. 
546 |a EN 
690 |a rhubarb 
690 |a trimethylamine N-oxide 
690 |a chronic kidney disease 
690 |a renal fibrosis 
690 |a gut microbiota 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 12 (2021) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2021.780924/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/ff84a8e94bf24e1aa1b176f84dbb0613  |z Connect to this object online.